Health Canada has approved MSD’s anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

Researchers found that, in patients with stage III NSCLC, treatment with cCRT and an ICI was safe, but treatment with cCRT and 2 ICIs led to “excessive mortality.” ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising driver of the disease and other risk factors.

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

LAKELAND, Fla. - Lakeland Regional Health is using new cutting-edge technology to help them cure lung cancer. Lung cancer can be a deadly disease, and the further it spreads, the more harmful it is.

Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...

Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

While the number of smokers in the world as a proportion of the population is dropping, lung cancer continues to cause almost ...